Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ128512890,16
KB0,00
PKN103,86103,880,23
Msft1,37
Nokia5,775,898-2,31
IBM0,27
Mercedes-Benz Group AG59,4559,48-0,38
PFE-2,83
15.11.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 14.11.2025
EDAP TMS SA Depository Receipt (NASDAQ Cons)
Závěr k 14.11.2025 Změna (%) Změna (USD) Objem obchodů (USD)
2,10 -0,94 -0,02 41 536
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiEdap Tms SA (ADR)
TickerEDAP
Kmenové akcie:ADR
RICEDAP.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.06.2025
Počet zaměstnanců k 31.12.2024 310
Akcie v oběhu k 30.06.2025 37 392 086
MěnaEUR
Kontaktní informace
UliceParc Activite
MěstoVAULX-EN-VELIN
PSČ69120
ZeměFrance
Kontatní osobaBlandine Confort
Funkce kontaktní osobyInvestor Relations Officer, Director - Legal Affairs
Telefon33 472 153 150
Fax33472153151
Kontatní telefon33 472 153 150

Business Summary: Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Financial Summary: BRIEF: For the six months ended 30 June 2025, Edap Tms SA (ADR) revenues decreased 4% to EUR29.6M. Net loss increased 19% to EUR12.7M. Revenues reflect Distribution Division segment decrease of 25% to EUR11.7M, ESWL Division segment decrease of 28% to EUR3.3M. Higher net loss reflects High Intensity Focused Ultrasound Division segment loss increase of 7% to EUR10.2M, Distribution Division segment loss increase from EUR173K to EUR650K.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICSSurgical and Medical Instrument Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICElectromedical Equipment
SICElectromedical Equipment
SICMedical And Hospital Equipment
SICSurgical And Medical Instruments



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Interim Independent Chairman of the BoardLance Willsey6330.09.202430.09.2024
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed IncRyan Rhodes6323.08.202312.06.2021
Chief Financial OfficerKenneth Mobeck5401.01.202401.01.2024
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)Jean-Francois Bachelard6101.01.1999
President of EDAP TMS France SASFrederic Pech5601.05.2023
Chief Accounting OfficerFrancois Dietsch4901.01.202414.07.2015
Investor Relations Officer, Director - Legal AffairsBlandine Confort-
General Manager of EDAP Switzerland GmbH, General Manager of EDAP TMS GmbHAlex Fromm-
General Manager of EDAP TMS KoreaJeon Jon-hyeon-
General Manager of EDAP Technomed (M) Sdn, BhdHerve De Soultrait-